Nanolucent Technologies, Inc. is working to commercialize an innovative computational imaging device and a cloud-based AI diagnostics platform for the rapid and accurate detection of cancers.
Nanolucent innovations are powered by technology developed by Lucendi, Inc. – a company spin-off from the UCLA Ozcan Research Group and based in Los Angeles. Founded in 2016, Lucendi is a leading innovator of AI-based holographic measurement systems. Lucendi holographic technology re-defines microscopic imaging by offering a more powerful and cost-effective solution across many applications.
Company’s Keywords:
artificial intelligence, machine learning, rapid cancer diagnostics, neural network, rapid cellular diagnostics
<2
<
<2019
Your request has been submitted successfully.
Own or work here?